InfuSystem Holdings (INFU) Long-Term Deferred Tax (2011 - 2026)
InfuSystem Holdings (INFU) posted Long-Term Deferred Tax of $4.2 million for Q1 2026, down 8.79% on a QoQ basis from $4.6 million in Q4 2025, and down 37.29% year-over-year from $6.7 million in Q1 2025.
InfuSystem Holdings (INFU) Long-Term Deferred Tax (2011 - 2026) Analysis & Trends
InfuSystem Holdings' Long-Term Deferred Tax history runs 14 years deep, the most recent figure standing at $4.2 million for Q1 2026.
- Quarterly Long-Term Deferred Tax fell 37.29% year-over-year to $4.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.2 million (down 37.29% YoY) and the FY2025 annual result came in at $4.6 million, down 35.45% from the prior year.
- Long-Term Deferred Tax was $4.2 million for Q1 2026 at InfuSystem Holdings, down from $4.6 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $10.3 million in Q1 2022 and bottomed at $4.2 million in Q1 2026.
- A 5-year average of $8.1 million and a median of $9.1 million in 2023 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2022 — Long-Term Deferred Tax rose 1.28% — and 2025, when it slumped 38.43%.
- InfuSystem Holdings' Long-Term Deferred Tax stood at $9.6 million in 2022, then slipped by 5.3% to $9.1 million in 2023, then fell by 21.14% to $7.2 million in 2024, then plunged by 35.45% to $4.6 million in 2025, then dropped by 8.79% to $4.2 million in 2026.
- Business Quant data shows INFU's Long-Term Deferred Tax at $4.2 million in Q1 2026, $4.6 million in Q4 2025, and $4.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.23 Mn |
| Dec 31, 2025 | 4.64 Mn |
| Sep 30, 2025 | 4.81 Mn |
| Jun 30, 2025 | 5.96 Mn |
| Mar 31, 2025 | 6.75 Mn |
| Dec 31, 2024 | 7.19 Mn |
| Sep 30, 2024 | 7.82 Mn |
| Jun 30, 2024 | 8.64 Mn |
| Mar 31, 2024 | 9.24 Mn |
| Dec 31, 2023 | 9.12 Mn |
| Sep 30, 2023 | 9.25 Mn |
| Jun 30, 2023 | 9.74 Mn |
| Mar 31, 2023 | 9.99 Mn |
| Dec 31, 2022 | 9.63 Mn |
| Sep 30, 2022 | 9.94 Mn |
| Jun 30, 2022 | 10.19 Mn |
| Mar 31, 2022 | 10.28 Mn |
| Dec 31, 2021 | 10.03 Mn |
| Sep 30, 2021 | 10.82 Mn |
| Jun 30, 2021 | 10.61 Mn |